Grace Therapeutics, Inc. Common Stock (GRCE)

$2.32 +1.09%

EARNINGS ANALYTICS

event_upcoming Next Earnings: 2026-06-22 HIGH CONFIDENCE

Across 20 earnings reports since Jun 22, 2021, Grace Therapeutics, Inc. Common Stock (GRCE) has a clear post-earnings pattern. It moves ±3.66% on average after reporting and finishes higher 60.0% of the time. Its largest post-earnings gain was +12.92% (Jun 22, 2021) and its largest decline was -10.21% (Nov 13, 2023). The next earnings report is predicted for 2026-06-22 (high confidence).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±3.66%

Positive %

60.0%

Negative %

40.0%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
Feb 12, 2026	☀ PRE	$3.61	$3.61	$3.54	2,225	-1.67%	open_in_new
Nov 13, 2025	☀ PRE	$3.06	$3.07	$3.05	1,240	-0.16%	open_in_new
Aug 12, 2025	☀ PRE	$3.15	$3.31	$3.17	3,866	+1.6%	open_in_new
Jun 23, 2025	☀ PRE	$2.91	$3.03	$2.97	405	-1.16%	open_in_new
Feb 13, 2025	☀ PRE	$3.45	$3.49	$3.49	598	+2.65%	open_in_new
Nov 13, 2024	☀ PRE	$3.25	$3.25	$3.25	0	+0%	open_in_new
Aug 09, 2024	☀ PRE	$2.38	$2.38	$2.38	100	-4.61%	open_in_new
Jun 21, 2024	☀ PRE	$3.25	$3.25	$3.25	100	+4.84%	open_in_new
Feb 12, 2024	☀ PRE	$2.64	$2.64	$2.61	618	+10.13%	open_in_new
Nov 13, 2023	☀ PRE	$2.12	$2.12	$2.11	450	-10.21%	open_in_new
Aug 11, 2023	☀ PRE	$2.36	$2.36	$2.36	126	-2.88%	open_in_new
Jun 23, 2023	☀ PRE	$0.56	$0.56	$0.56	0	+0%	open_in_new
Feb 14, 2023	☀ PRE	$0.65	$0.65	$0.65	300	+3.16%	open_in_new
Nov 14, 2022	☀ PRE	$0.52	$0.52	$0.52	100	+2.9%	open_in_new
Aug 11, 2022	☀ PRE	$0.91	$0.91	$0.91	245	+4%	open_in_new
Jun 21, 2022	☀ PRE	$0.93	$0.94	$0.94	300	+5.24%	open_in_new
Feb 14, 2022	☀ PRE	$1.21	$1.21	$1.21	155	+2.54%	open_in_new
Nov 10, 2021	☀ PRE	$1.71	$1.71	$1.67	800	-2.06%	open_in_new
Aug 12, 2021	☽ POST	$0.45	$0.45	$0.45	1,334	-0.38%	open_in_new
Jun 22, 2021	☀ PRE	$0.50	$0.56	$0.54	79,222	+12.92%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.66%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

description 8-K

1 chevron_right

description SCHEDULE 13G/A

1 chevron_right

Recent SEC Filings

2 most recent

Form	Date Filed	View on EDGAR
8-K	20260605	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov

Frequently asked about GRCE earnings

When does Grace Therapeutics, Inc. Common Stock report earnings next? expand_more

Grace Therapeutics, Inc. Common Stock (GRCE)'s next earnings date is predicted (high confidence) for 2026-06-22. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does GRCE stock move after earnings? expand_more

Over 20 reports, GRCE has moved an average of ±3.66% the session after earnings, closing higher 60.0% of the time.

What was GRCE's biggest post-earnings move? expand_more

GRCE's largest post-earnings gain on record was +12.92% on Jun 22, 2021, and its largest decline was -10.21% on Nov 13, 2023.

Where can I find Grace Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Grace Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.